stressROP: Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided

Sponsor
Aristotle University Of Thessaloniki (Other)
Overall Status
Completed
CT.gov ID
NCT04408807
Collaborator
(none)
37
1
2
5.8
6.4

Study Details

Study Description

Brief Summary

The purpose is to assess the hypothesis that indirect ophthalmoscopy for retinopathy of prematurity eye examination (ROPEE) screening without the use of a lid speculum and scleral indentation (speculum-free, SpF) is less painful/stressful than funduscopy with speculum (Sp) and scleral indentation.

Condition or Disease Intervention/Treatment Phase
  • Other: Speculum-free (SpF) fundoscopy
  • Other: Speculum (Sp) fundoscopy
N/A

Detailed Description

A prospective randomized cross-over study was conducted for the comparison of the two techniques of funduscopy for ROPEE screening, i.e. with (Sp) or without (SpF) the use of a speculum and indentor. A random number table was used to allocate participants into either a) receiving Sp funduscopy on their first and SpF on their second screening examination a week later, or b) receiving SpF first and Sp a week later.

Study Design

Study Type:
Interventional
Actual Enrollment :
37 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Stress Induced by Screening for Retinopathy of Prematurity - Should Speculum and Indentation Rather be Avoided
Actual Study Start Date :
Sep 3, 2019
Actual Primary Completion Date :
Feb 4, 2020
Actual Study Completion Date :
Feb 27, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Study Group

ROPEE screening with speculum-free fundoscopy

Other: Speculum-free (SpF) fundoscopy
Indirect ophthalmoscopy without the use of eyelid speculum and scleral indentation

Active Comparator: Control Group

ROPEE screening with speculum fundoscopy

Other: Speculum (Sp) fundoscopy
Indirect ophthalmoscopy with the use of eyelid speculum and scleral indentation

Outcome Measures

Primary Outcome Measures

  1. Premature Infant Pain Profile-Revised score (PIPP) [a) before the intervention [the effect of mydriasis (PIPP1)] b) at the end of the intervention [the effect of funduscopy (PIPP2)] c) 10-20 minutes after the intervention [the overall effect of the examination, i.e. mydriasis and funduscopy (PIPP3)]]

Secondary Outcome Measures

  1. Crying score of the Bernese pain scale [During the examination]

  2. Adverse events including arrythmia/bradycardia, apnoea, increased oxygen demands and feed intolerance [During the examination and during the 24 hours after the examination]

  3. Adequacy of judging the presence of treatment-requiring ROP [At the end of ROPEE screening]

  4. Duration of fundoscopy [During the examination]

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Weeks to 37 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Preterm neonates undergoing screening for ROP, i.e.

  • with GA < 32weeks and/or BW < 1501grams

  • infants of greater BW and GA with increased comorbidity, e.g. sepsis, prolonged need for oxygen supplementation etc., as judged by the attending neonatologist

Exclusion Criteria:
  1. Severe clinical condition with unstable vital signs to the extent that stress is not desired and the examination need to be postponed.

  2. Diagnosis of traumatic apoptosis of the corneal epithelium / corneal ulcer.

  3. Neonates under sedative/analgesic treatment.

  4. Intraventricular hemorrhage (III,IV degree), moderate/severe neurological impairment, other conditions that could alter pain response.

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Papageorgiou" Hospital Thessaloniki Greece

Sponsors and Collaborators

  • Aristotle University Of Thessaloniki

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Asimina Mataftsi, Associate Professor in Ophthalmology, Paediatric Ophthalmology and Strabismus, Aristotle University Of Thessaloniki
ClinicalTrials.gov Identifier:
NCT04408807
Other Study ID Numbers:
  • 414/08-05-2019
First Posted:
May 29, 2020
Last Update Posted:
Mar 24, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 24, 2022